The Securities and Exchange Board of India (SEBI) has reportedly unveiled new norms for the issuance of Depository Receipts (DR) by Indian companies.
According to sources, the listed companies will soon be allowed to compete in the international exchanges such as the New York Stock Exchange (NYSE), Hong Kong Stock Exchange (HKSE), and Nasdaq among others.
With the new framework put in place, the market regulator will now be able to monitor the process of issuing DRs by Indian companies which were not being overseen. On the same lines, SEBI also believes that it will help Indian companies raise capital overseas.
Though unlisted companies will not be permitted to issue depository receipts, SEBI stated that such companies could issue DRs simultaneously once they are listed in the domestic markets. The market regulator has also barred companies from issuing DRs in unrecognised/unreliable or smaller exchanges to prevent manipulation.
According to reports, Indian citizens, as well as non-resident Indians (NRIs) will be barred from investing in Indian companies’ issued DRs. Also, companies will not be allowed to issue DRs overseas for a value that is below the domestic market price as per the new norms.
Companies can begin filing the DR issuance documents with the market regulator, post which the request will be approved within 7 working days.
For any clarifications/feedback on the topic, please contact the writer at firstname.lastname@example.org.